Log In
Print
BCIQ
Print
Print this Print this
 

Long-acting pegylated Factor IX

  Manage Alerts
Collapse Summary General Information
Company Pro Bono Bio Group plc
DescriptionRecombinant Factor IX proteins conjugated to a polyethylene glycol molecule using PolyTherics' TheraPEG technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia
Regulatory Designation
Partner Abzena plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today